By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Supreme Court today invalidated two patents held by Prometheus Laboratories in a widely watched case for those involved in the personalized medicine field.

In a unanimous decision, the court called the patents in dispute, US Patent Nos. 6,355,623 and 6,680,302 unpatentable because they merely describe the laws of nature and "add nothing specific to the laws of nature other than what is well-understood, routine, conventional activity."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.